Company: DMAAR
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-076681
Chunk: 82

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 8
Chunk 82
---
, share capitalizations, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing after our initial business combination and (ii) with
respect to the remaining 50% of the Private Placement Units, six months after the date of the consummation of our initial business combination,
or earlier, in either case, if, subsequent to our initial business combination, we consummate a liquidation, merger, share exchange or
other similar transaction which results in all of our shareholders having the right to exchange their ordinary shares for cash, securities
or other property. The sponsor was granted certain demand and piggyback registration rights in connection with the purchase of the Private
Placement Units. No underwriting discounts or commissions were paid with respect to such sale. The Private Placement Units were issued
pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”).

Subsequently, the underwriters exercised the over-allotment
option in full, and the closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred
on February 18, 2025. The total aggregate issuance by us of 3,000,000 Over-Allotment Option Units at a price of $10.00 per unit resulted
in total gross proceeds of $30,000,000. On February 18, 2025, simultaneously with the sale of the Over-Allotment Option Units, we consummated
the private sale of an additional 30,000 Private Placement Units, generating gross proceeds of $300,000.

Following the closing of the IPO, a total of $
231,150,000 of the net proceeds from the sale of Units in the IPO (including the Over-Allotment Option Units) and the private placement
of the Private Placement Units, were placed in a trust account established for the benefit of the Company’s public shareholders
(the “trust account”) established by VStock Transfer, LLC, our transfer agent and maintained by Wilmington Trust, National
Association acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to us
to pay our taxes, if any, the funds held in the trust account will not be released from the trust account until the earliest to occur
of: (1) our completion of an initial